Zr-89-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study.
Brian M. Shuch,Allan J. Pantuck,Jean-Christophe Bernhard,Michael Morris,Viraj A. Master,Andrew Mark Scott, Charles Van Praet,Clement Bailly,Bulent Onal,Tamer Aksoy,Robin Merkx,David M. Schuster,Sze Ting Lee,Neeta Pandit-Taskar,Alice C. Fan, Libuse Tauchmanova,Karl Schmidt, Kavita Vadali, Colin Hayward,Peter Mulders JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
